309 related articles for article (PubMed ID: 28582317)
21. Acute Exacerbation in Interstitial Lung Disease.
Leuschner G; Behr J
Front Med (Lausanne); 2017; 4():176. PubMed ID: 29109947
[TBL] [Abstract][Full Text] [Related]
22. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
[TBL] [Abstract][Full Text] [Related]
23. Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography.
Suzuki H; Sekine Y; Yoshida S; Suzuki M; Shibuya K; Yonemori Y; Hiroshima K; Nakatani Y; Mizuno S; Takiguchi Y; Yoshino I
Surg Today; 2011 Jul; 41(7):914-21. PubMed ID: 21748606
[TBL] [Abstract][Full Text] [Related]
24. Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
Cuerpo S; Moisés J; Hernández-González F; Benegas M; Ramirez J; Sánchez M; Agustí À; Sellares J
Chron Respir Dis; 2019; 16():1479973119869334. PubMed ID: 31431063
[TBL] [Abstract][Full Text] [Related]
25. [Exacerbation of idiopathic pulmonary fibrosis].
Avdeev SN; Gaynitdinova VV; Merzhoeva ZM; Neklyudova GV; Tsareva NA; Nuralieva GS
Ter Arkh; 2020 Apr; 92(3):73-77. PubMed ID: 32598796
[TBL] [Abstract][Full Text] [Related]
26. Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique.
Maher TM; Whyte MK; Hoyles RK; Parfrey H; Ochiai Y; Mathieson N; Turnbull A; Williamson N; Bennett BM
Adv Ther; 2015 Oct; 32(10):929-43. PubMed ID: 26498943
[TBL] [Abstract][Full Text] [Related]
27. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Collard HR; Ryerson CJ; Corte TJ; Jenkins G; Kondoh Y; Lederer DJ; Lee JS; Maher TM; Wells AU; Antoniou KM; Behr J; Brown KK; Cottin V; Flaherty KR; Fukuoka J; Hansell DM; Johkoh T; Kaminski N; Kim DS; Kolb M; Lynch DA; Myers JL; Raghu G; Richeldi L; Taniguchi H; Martinez FJ
Am J Respir Crit Care Med; 2016 Aug; 194(3):265-75. PubMed ID: 27299520
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic pulmonary fibrosis: evolving concepts.
Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
[TBL] [Abstract][Full Text] [Related]
29. Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report.
Ikeda S; Sekine A; Baba T; Yamakawa H; Morita M; Kitamura H; Ogura T
BMC Pulm Med; 2016 Mar; 16():38. PubMed ID: 26940352
[TBL] [Abstract][Full Text] [Related]
30. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
[TBL] [Abstract][Full Text] [Related]
31. An Acute Exacerbation of Idiopathic Pulmonary Fibrosis After BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
Ghincea A; Ryu C; Herzog EL
Chest; 2022 Feb; 161(2):e71-e73. PubMed ID: 35131075
[TBL] [Abstract][Full Text] [Related]
32. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
[TBL] [Abstract][Full Text] [Related]
33. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
Luppi F; Cerri S; Taddei S; Ferrara G; Cottin V
Intern Emerg Med; 2015 Jun; 10(4):401-11. PubMed ID: 25672832
[TBL] [Abstract][Full Text] [Related]
34. Severe idiopathic pulmonary fibrosis: A clinical approach.
Lipsi R; Mazzola D; Caminati A; Elia D; Lonati C; Harari S
Eur J Intern Med; 2018 Apr; 50():20-27. PubMed ID: 29361476
[TBL] [Abstract][Full Text] [Related]
35. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases.
Saraya T; Kimura H; Kurai D; Tamura M; Ogawa Y; Mikura S; Sada M; Oda M; Watanabe T; Ohkuma K; Inoue M; Honda K; Watanabe M; Yokoyama T; Fujiwara M; Ishii H; Takizawa H
Respir Med; 2018 Mar; 136():88-92. PubMed ID: 29501253
[TBL] [Abstract][Full Text] [Related]
37. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
[TBL] [Abstract][Full Text] [Related]
38. [Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment].
Behr J
Dtsch Med Wochenschr; 2012 Mar; 137(12):601-4. PubMed ID: 22415624
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic pulmonary fibrosis: pathogenesis and management.
Sgalla G; Iovene B; Calvello M; Ori M; Varone F; Richeldi L
Respir Res; 2018 Feb; 19(1):32. PubMed ID: 29471816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
